Hospital
Sinai Hospital of Baltimore, INC.
Sinai Hospital of Baltimore, INC. was paid $10.24M by Medicaid between Jan 2018 and Dec 2024, across 157 billing codes. Its largest line is 41899, Unlisted procedure, dentoalveolar structures — 31% of everything it billed.
33Billing provider infoSINAI HOSPITAL OF BALTIMORE, INC.
BALTIMORE, MD 21215
BALTIMORE, MD 21215
33aNPI1285672204assigned 06/03/2006
33bProvider typeGeneral Acute Care Hospital
28Total paid$10.24M
24GClaims222,166
24DCodes billed157
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other General Acute Care Hospital providers in Maryland
Rank by total paid#2 of 69
Median peer was paid$870K
This provider vs. median12×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 44,588 | $2.14M | |
| 2019 | 36,934 | $2.16M | |
| 2020 | 26,815 | $1.15M | |
| 2021 | 30,300 | $1.26M | |
| 2022 | 32,832 | $1.35M | |
| 2023 | 33,366 | $1.57M | |
| 2024incomplete | 17,331 | $609K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 41899 | Unlisted procedure, dentoalveolar structures | 31% | 881 | 842 | $3.22M |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 15% | 7,137 | 6,611 | $1.54M |
| G0378 | Hospital observation service, per hour | 12% | 2,484 | 2,131 | $1.26M |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 9.8% | 6,605 | 6,092 | $999K |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 3.7% | 3,870 | 3,532 | $379K |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | 3.5% | 9,992 | 8,230 | $362K |
| 90837 | Psychotherapy session, about an hourPsychotherapy, 53 minutes with patient | 3.3% | 2,290 | 1,824 | $340K |
| 92014 | Ophthalmological services: medical examination and evaluation, comprehensive, established patient | 2.3% | 5,399 | 5,088 | $237K |
| 90832 | Psychotherapy session, about 30 minutesPsychotherapy, 30 minutes with patient | 2.1% | 3,478 | 3,180 | $213K |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | 1.8% | 3,587 | 1,622 | $189K |
| 96413 | Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance | 1.4% | 1,539 | 939 | $147K |
| 92134 | 1.3% | 1,193 | 1,121 | $137K |
145 more codes
| 92133 | 1.2% | 1,274 | $128K | |
| 86850 | 1.2% | 1,564 | $123K | |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 1.0% | 4,824 | $106K |
| 80053 | Comprehensive metabolic panel | <1% | 16,932 | $85K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 585 | $84K |
| 92083 | <1% | 574 | $69K | |
| 92012 | Ophthalmological services: medical examination and evaluation, intermediate, established patient | <1% | 1,748 | $60K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 7,184 | $60K |
| 90834 | Psychotherapy session, about 45 minutes | <1% | 593 | $52K |
| 20610 | <1% | 1,630 | $50K | |
| 97162 | <1% | 742 | $47K | |
| 97161 | <1% | 410 | $36K | |
| C7901 | Service for diagnosis, evaluation, or treatment of a mental health or substance use disorder, 30-60 minutes, provided remotely by hospital staff who are licensed to provided mental health services under applicable state law(s), when the patient is in their home, and there is no associated professional service | <1% | 241 | $34K |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 845 | $31K |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 2,369 | $26K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | <1% | 380 | $21K |
| 90791 | Psychiatric diagnostic evaluation | <1% | 269 | $21K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | <1% | 1,394 | $19K |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | <1% | 1,595 | $16K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | <1% | 3,138 | $16K |
| 82947 | <1% | 93 | $11K | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 1,780 | $10K |
| 73560 | <1% | 324 | $9K | |
| 0202U | Oncology (prostate), multianalyte, gene expression profiling | <1% | 116 | $8K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 4,059 | $8K |
| 84484 | <1% | 6,473 | $6K | |
| 85027 | <1% | 14,629 | $6K | |
| 82330 | <1% | 906 | $6K | |
| 99213 | Doctor's office visit, returning patient (routine) | <1% | 247 | $5K |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 3,581 | $5K |
| 72125 | Computed tomography, cervical spine; without contrast material | <1% | 1,259 | $4K |
| 97112 | Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination | <1% | 268 | $4K |
| 98968 | <1% | 84 | $3K | |
| 83735 | <1% | 9,139 | $3K | |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 7,786 | $3K |
| 93971 | <1% | 100 | $3K | |
| 45378 | Colonoscopy, flexible; diagnostic, including collection of specimen(s) | <1% | 12 | $3K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 237 | $2K |
| 71260 | Computed tomography, thorax, diagnostic; with contrast material | <1% | 283 | $2K |
| 83605 | <1% | 3,749 | $2K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 935 | $2K |
| 36591 | <1% | 566 | $2K | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 7,872 | $2K |
| 87088 | <1% | 1,169 | $1K | |
| 67028 | Intravitreal injection of a pharmacologic agent | <1% | 30 | $1K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 399 | $1K |
| 71045 | Radiologic examination, chest; single view | <1% | 3,397 | $1K |
| J0690 | Injection, cefazolin sodium, 500 mg | <1% | 536 | $994.32 |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 104 | $861.76 |
| 96523 | <1% | 82 | $739.43 | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 2,891 | $677.07 |
| 86900 | <1% | 1,603 | $585.13 | |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | <1% | 487 | $556.65 |
| 81001 | <1% | 6,203 | $553.45 | |
| U0004 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r | <1% | 204 | $548.15 |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 1,512 | $485.35 |
| 85610 | <1% | 2,993 | $433.93 | |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | <1% | 116 | $431.62 |
| 97165 | <1% | 27 | $397.61 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 916 | $367.57 |
| 97166 | <1% | 133 | $337.47 | |
| 69210 | <1% | 34 | $309.76 | |
| 71275 | Computed tomographic angiography, chest, with contrast material | <1% | 182 | $301.84 |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | <1% | 178 | $275.44 |
| J1631 | Injection, haloperidol decanoate, per 50 mg | <1% | 61 | $274.94 |
| 73030 | <1% | 148 | $256.65 | |
| 88342 | <1% | 57 | $232.10 | |
| A4663 | Blood pressure cuff only | <1% | 84 | $218.45 |
| A4606 | Oxygen probe for use with oximeter device, replacement | <1% | 66 | $191.40 |
| 84100 | <1% | 5,357 | $186.04 | |
| J0330 | Injection, succinylcholine chloride, up to 20 mg | <1% | 224 | $180.06 |
| 85730 | <1% | 1,130 | $171.83 | |
| 82803 | <1% | 443 | $167.76 | |
| 83690 | <1% | 2,398 | $162.80 | |
| 97116 | <1% | 38 | $158.20 | |
| 85014 | <1% | 382 | $136.22 | |
| J0171 | Injection, adrenalin, epinephrine, 0.1 mg | <1% | 92 | $132.65 |
| E1352 | Oxygen accessory, flow regulator capable of positive inspiratory pressure | <1% | 17 | $129.18 |
| 76376 | <1% | 25 | $128.70 | |
| 93017 | <1% | 94 | $121.15 | |
| 86901 | <1% | 1,605 | $116.51 | |
| 71250 | <1% | 27 | $112.41 | |
| 84145 | <1% | 28 | $109.77 | |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | <1% | 763 | $99.84 |
| 73610 | <1% | 15 | $89.49 | |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 1,891 | $89.44 |
| 73562 | <1% | 120 | $88.74 | |
| J1642 | Injection, heparin sodium, (heparin lock flush), per 10 units | <1% | 3,360 | $87.00 |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 627 | $72.97 |
| J1644 | Injection, heparin sodium, per 1000 units | <1% | 2,554 | $66.83 |
| J3475 | Injection, magnesium sulfate, per 500 mg | <1% | 858 | $51.88 |
| 73630 | <1% | 105 | $49.54 | |
| J2704 | Injection, propofol, 10 mg | <1% | 941 | $49.43 |
| J1650 | Injection, enoxaparin sodium, 10 mg | <1% | 1,071 | $48.47 |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 1,257 | $38.79 |
| 83880 | <1% | 1,820 | $30.15 | |
| 87186 | <1% | 71 | $25.93 | |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | <1% | 1,642 | $22.18 |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 312 | $19.54 |
| 80320 | <1% | 582 | $17.67 | |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | <1% | 796 | $16.81 |
| J2370 | Injection, phenylephrine hcl, up to 1 ml | <1% | 138 | $9.18 |
| J1170 | Injection, hydromorphone, up to 4 mg | <1% | 96 | $7.92 |
| 82248 | <1% | 553 | $5.03 | |
| J2060 | Injection, lorazepam, 2 mg | <1% | 52 | $2.00 |
| G8979 | Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting | <1% | 530 | $0.04 |
| G8978 | Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals | <1% | 530 | $0.04 |
| G8988 | Self care functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting | <1% | 177 | $0.01 |
| G8987 | Self care functional limitation, current status, at therapy episode outset and at reporting intervals | <1% | 174 | $0.01 |
| 82565 | 0% | 81 | $0.00 | |
| 76000 | 0% | 13 | $0.00 | |
| 84439 | 0% | 199 | $0.00 | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 0% | 49 | $0.00 |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | 0% | 109 | $0.00 |
| A9502 | Technetium tc-99m tetrofosmin, diagnostic, per study dose | 0% | 80 | $0.00 |
| 84295 | 0% | 86 | $0.00 | |
| 85007 | 0% | 69 | $0.00 | |
| 84588 | 0% | 40 | $0.00 | |
| J2272 | Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg | 0% | 14 | $0.00 |
| 73565 | 0% | 12 | $0.00 | |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | 0% | 12 | $0.00 |
| 87899 | 0% | 56 | $0.00 | |
| 82533 | 0% | 78 | $0.00 | |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | 0% | 982 | $0.00 |
| 84443 | Thyroid stimulating hormone (TSH) | 0% | 940 | $0.00 |
| 82435 | 0% | 84 | $0.00 | |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | 0% | 59 | $0.00 |
| 83550 | 0% | 16 | $0.00 | |
| 85379 | 0% | 172 | $0.00 | |
| 84132 | 0% | 172 | $0.00 | |
| 82728 | 0% | 151 | $0.00 | |
| 87040 | 0% | 201 | $0.00 | |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 0% | 126 | $0.00 |
| 83615 | 0% | 45 | $0.00 | |
| 86140 | 0% | 98 | $0.00 | |
| 82150 | 0% | 30 | $0.00 | |
| 84703 | 0% | 110 | $0.00 | |
| 96375 | Therapeutic injection; each additional sequential IV push | 0% | 166 | $0.00 |
| 85651 | 0% | 13 | $0.00 | |
| J3010 | Injection, fentanyl citrate, 0.1 mg | 0% | 61 | $0.00 |
| 36415 | Collection of venous blood by venipuncture | 0% | 26 | $0.00 |
| J0360 | Injection, hydralazine hcl, up to 20 mg | 0% | 18 | $0.00 |
| 83036 | Hemoglobin; glycosylated (A1C) | 0% | 18 | $0.00 |
| J2785 | Injection, regadenoson, 0.1 mg | 0% | 14 | $0.00 |
| 70486 | 0% | 15 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialSHLOSSMAN, AMY (PRESIDENT)
| Provider | Location | Paid |
|---|---|---|
| Grace Medical Center, INC. | Baltimore, MD | $1.10M |
| Grace Medical Center, INC. | Baltimore, MD | $657K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.